Increased P2X7 receptor expression and function in thyroid papillary cancer: A new potential marker of the disease?

Endocrinology

Volumn 149, Issue 1, 2008, Pages 389-396

  Solini, Anna ^a   Cuccato, Sabina ^a   Ferrari, Davide ^a   Santini, Eleonora ^a   Gulinelli, Sara ^b   Callegari, Maria Giulia ^b   Dardano, Angela ^a   Faviana, Pinuccia ^a   Madec, Stephanie ^a   Di Virgilio, Francesco ^b   Monzani, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; INTERLEUKIN 6; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC P2 RECEPTOR; TUMOR MARKER;

ANAPLASTIC CARCINOMA; ARTICLE; CALCIUM CELL LEVEL; CANCER GRADING; CANCER STAGING; CYTOKINE RELEASE; DISEASE MARKER; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID PAPILLARY CARCINOMA; UPREGULATION; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAPILLARY CARCINOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; THYROID GLAND; THYROID TUMOR; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; RECEPTORS, PURINERGIC P2; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 37549030561     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1223     Document Type: Article

References (32)

1. Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang Y, Caldwell S, Liu K, Smith P, Chen JF, Jackson EK, Apasov S, Abrams S, Sitkowsky M 2006 A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 103:13132-13137
2. Burnstock G 2006 Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58-86
3. White N, Burnstock G 2006 P2 receptors and cancer. Trends Pharmacol Sci 27:211-217
4. 7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99: 706-708
5. Slater M, Danieletto S, Pooley M, Cheng Teh L, Gidley-Baird A, Barden JA 2004 Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat 83:1-10
6. Slater M, Danieletto S, Gidley-Baird A, Cheng Teh L, Barden JA 2004 Early prostate cancer detected using expression of nonfunctional cytolytic P2X7 receptors. Histopathology 44:206-215
7. Raffaghello L, Chiozzi P, Falzoni S, Di Virgilio F, Pistoia V 2006 The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res 66:907-914
8. Adinolfi E, Callegari MG, Ferrari D, Bolognesi C, Minelli M, Wieckowski MR, Pinton P, Rizzuto R, Di Virgilio F 2005 Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol Biol Cell 16:3260-3272
9. Caraccio N, Monzani F, Santini E, Cuccato S, Ferrari D, Callegari MG, Gulinelli S, Pizzirani C, Di Virgilio F, Ferrannini E, Solini A 2005 Extracellular adenosine 5′-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. Endocrinology 146:3172-3178
10. Petersen C, Froysa B, Soder O 2004 Endotoxin and proinflammatory cytokines modulate Sertoli cell proliferation in vitro. J Reprod Immunol 61:13-30
11. Willenberg HS, Path G, Vogeli TA, Scherbaum WA, Bornstein SR 2002 Role of interleukin-6 in stress response in normal and tumorous adrenal cells and during chronic inflammation. Ann NY Acad Sci 966:304-314
12. Dean DS, Hay ID 2000 Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 7:229-239
13. Al-Brahim N, Asa SL 2006 Papillary thyroid carcinoma: an overview. Arch Pathol Lab Med 130:1057-1062
14. Pines A, Bivi N, Vascotto C, Romanello M, D'Ambrosio C, Scaloni A, Damante G, Morisi R, Filetti S, Ferretti E, Quadrifoglio F, Tell G 2006 Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway. J Cell Physiol 209:44-55
15. Green ST 1987 Intrathyroidal autonomic nerves can directly influence hormone release from rat thyroid follicles: a study in vitro employing electrical field stimulation and intracellular microelectrodes. Clin Sci (Lond) 72:233-238
16. Schwiebert LM, Rice WC, Kudlow BA, Taylor AL, Schwiebert EM 2002 Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol Cell Physiol 282: C289-C301
17. 7 receptor stimulates plasma membrane trafficking in the FRTL rat thyrocyte cell line. Am J Physiol Cell Physiol 287:C992-C1002
18. Schofl C, Rossig L, Potter E, von zur Muhlen A, Brabant G 1995 Extracellular ATP and UTP increase cytosolic free calcium by activating a common P2u-receptor in single human thyrocytes. Biochem Biophys Res Commun 213:928-934
19. Di Jeso B, Laviola L, Liguoro D, Formisano S, Consiglio E 1993 P2 purinergic agonists and 12-O-tetradecanoylphorbol-13-acetate, as well as protein kinase A activators, stimulate thyroglobulin secretion in FRTL-5 cells. Biochem Biophys Res Commun 191:385-391
20. Ekokoski E, Webb TE, Simon J, Tornquist, K 2001 Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells. J Cell Physiol 187:166-175
21. Fiore L, Pollina LE, Fontanini G, Casalone R, Berlingieri MT, Giannini R, Pacini F, Miccoli P, Toniolo A, Fusco A, Basolo F 1997 Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1. J Clin Endocrinol Metab 82:4094-4100
22. Basolo F, Giannini R, Toniolo A, Casalone R, Nikiforova M, Pacini F, Elisei R, Miccoli P, Berti P, Faviana P, Fiore L, Monaco C, Pierantoni GM, Fedele M, Nikiforov YE, Santoro M, Fusco A 2002 Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement. Int J Cancer 97:608-614
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450
24. Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N 1998 Increased serum concentration of interleukin-5 in patients with Grave's disease and Hashimoto's thyroiditis. Thyroid 8:235-239
25. Bartalena L, Brogioni S, Grasso L, Martino E 1995 Interleukin-6 and the thyroid. Eur J Endocrinol 132:386-393
26. Watkinson JC, Franklyn JA, Olliff JF 2006 Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer. Thyroid 16:187-194
27. Wagstaff SC, Bowler WB, Gallagher JA, Hipskind RA 2000 Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells. Carcinogenesis 21:2175-2181
28. Coutinho-Silva R, Stahl L, Cheung KK, de Campos NE, de Oliveira Souza C, Ojcius DM, Burnstock G 2005 P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol 288: G1024-G1035
29. Yoon MJ, Lee HJ, Kim JH, Kim DK 2006 Extracellular ATP induces apoptotic signaling in human monocyte leukemic cells, HL-60 and F-36P. Arch Pharm Res 29:1032-1041
30. 7 receptor-mediated apoptosis of human cervical epithelial cells. Am J Physiol Cell Physiol 287:C1349-C1358
31. Barton BE 2005 Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes. Expert Opin Ther Targets 9:737-752
32. Ruggeri RM, Villari D, Simone A, Scarfi R, Attard M, Orlandi F, Barresi G, Trimarchi F, Trovato M, Benvenga S 2002 Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor. J Endocrinol Invest 25:959-966